Core Laboratories (CLB) Tops Q2 EPS by 1c, Revenues Miss; Q3 EPS Mid-Point Guidance Below Consensus, Q3 Rev. Outlook Below Consensus
Tweet Send to a Friend
Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
